MichaelVanceMolyneauxMD

Chief Medical Officer, Sirnaomics, Inc.

Dr. Molyneaux is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
30011 Ivy Glenn Dr
Ste 215
Laguna Niguel, CA 92677
Phone+1 949-403-0828

Fax+1 949-481-9353

Journal Articles

Enhanced Angiogenesis and Collagen Density by Living Human Activated Leukocyte Suspension (LHALS) in a Splinted Full-Thickness Dermal Wound Model
Shah, V., Li, W., Molyneaux, M, Symposium On Advanced Wound Care, 1/1/2015
A Multicenter Randomized Dosing Trial of Spray-Applied Cell Therapy with Human Allogeneic Fibroblasts and Keratinocytes for the Treatment of Chronic Venous Leg Ulcers ...
Lancet, 1/1/2014
Biological Properties of a Living Human Activated Leukocyte Suspension (LHALS) And Its Association with Wound Healing and Tissue Remodeling
Shah, V., Shik, P., Li, W., Molyneaux, M., Zuloff-Shani, A., Wound Healing Society, 1/1/2014
Wound Healing Acceleration by Living Human Activated Leukocyte Suspension (LHALS) In A Splinted Full-Thickness Dermal Wound Model
Shah, V., Li, W., Molyneaux, M., Wound Healing Society, 1/1/2014
Growth Factor Characterization of Living Human Activated Leukocyte Suspension (LHALS) And Effect On Primary Human Corneal Epithelial Cell Proliferation
Shah, V., Li, W., Molyneaux, M., The Association for Research in Vision and Ophthalmology (ARVO), 1/1/2014
DSC127 Stimulation of Diabetic Foot Ulcer Healing: Results of a Randomized, Parallel-Group, and Double Blind, Placebo-Controlled Phase 2 Clinical Trials
Wound Repair and Regenerative Medicine, 1/1/2012
Macrophages: A Review of Their Role in Wound Healing and Their Therapeutic Use
Snyder, R.J., Lantis, J., Kirsner, R., Shah, V., Molyneaux M., Wound Repair and Regeneration, 1/14/2016
Join now to see all

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin CancersFebruary 1st, 2023
Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma in SituDecember 14th, 2022
Sirnaomics Will Present Clinical Study Results and Development Strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China SummitMay 20th, 2022
Join now to see all